Led by Stanford University School of Medicine’s Department of Urology, researchers found that Avenda Health’s machine learning model, Unfold AI, and novel cancer probability metric was shown to be accurate and effective in identifying the extent of the cancer, not just location.
The European Society For Medical Oncology has formally weighed in on a question that U.S. medical groups have been chipping away at as well: How can we guarantee safe and effective use of artificial intelligence in oncology?
